Cargando…

Subcutaneous Ketamine in Depression: A Systematic Review

Background: Ketamine has been shown to produce a rapid and robust antidepressant effect. Though numerous routes of administration have been studied, subcutaneous (SC) has proven to be a convenient and cost-effective route making its use particularly relevant in developing countries. Here we provide...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cavenaghi, Vitor Breseghello, da Costa, Leandro Paulino, Lacerda, Acioly Luiz Tavares, Hirata, Edson Shiguemi, Miguel, Eurípedes Constantino, Fraguas, Renério
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8193034/ https://www.ncbi.nlm.nih.gov/pubmed/34122156 http://dx.doi.org/10.3389/fpsyt.2021.513068

Ejemplares similares

Esketamine/ketamine for treatment-resistant depression
por: Lacerda, Acioly L.T.
Publicado: (2020)

Ketamine study: Protocol for naturalistic prospective multicenter study on subcutaneous ketamine infusion in depressed patients with active suicidal ideation
por: Anzolin, Ana Paula, et al.
Publicado: (2023)

A Clinical Rationale for Assessing the Impact of Childhood Sexual Abuse on Adjunctive Subcutaneous Esketamine for Treatment-Resistant Depression
por: Magalhães, Eduardo Jorge Muniz, et al.
Publicado: (2021)

A Systematic Review of Non-Invasive Brain Stimulation Therapies and Cardiovascular Risk: Implications for the Treatment of Major Depressive Disorder
por: Sampaio, Leonardo Augusto Negreiros Parente Capela, et al.
Publicado: (2012)

The Influence of Depression on the Psychometric Properties of the Maslach Burnout Inventory–Human Services Survey: A Cross-Sectional Study With Nursing Assistants
por: Trigo, Telma R., et al.
Publicado: (2018)

The Effect of Ketamine on Electrophysiological Connectivity in Major Depressive Disorder
por: Nugent, Allison C., et al.
Publicado: (2020)

Ketamine for Bipolar Depression: Biochemical, Psychotherapeutic, and Psychedelic Approaches
por: Bennett, Raquel, et al.
Publicado: (2022)

Antianhedonic Effect of Repeated Ketamine Infusions in Patients With Treatment Resistant Depression
por: Wilkowska, Alina, et al.
Publicado: (2021)

Gender differences in the antianhedonic effects of repeated ketamine infusions in patients with depression
por: Zheng, Wei, et al.
Publicado: (2022)

Hippocampal subfield volumes in treatment resistant depression and serial ketamine treatment
por: Zavaliangos-Petropulu, Artemis, et al.
Publicado: (2023)

Pharmacological and combined interventions for the acute depressive episode: focus on efficacy and tolerability
por: Brunoni, Andre R, et al.
Publicado: (2009)

Neural and Behavioral Correlates of Clinical Improvement to Ketamine in Adolescents With Treatment Resistant Depression
por: Thai, Michelle, et al.
Publicado: (2020)

Plasma VEGF Concentrations and Ketamine's Effects on Suicidal Ideation in Depression With Suicidal Ideation
por: Zheng, Wei, et al.
Publicado: (2022)

Pre-treatment Pain Symptoms Influence Antidepressant Response to Ketamine in Depressive Patients
por: Lan, Xiaofeng, et al.
Publicado: (2022)

Depression, Estrogens, and Neuroinflammation: A Preclinical Review of Ketamine Treatment for Mood Disorders in Women
por: Gagne, Collin, et al.
Publicado: (2022)

Association of VEGF With Antianhedonic Effects of Repeated-Dose Intravenous Ketamine in Treatment-Refractory Depression
por: Zheng, Wei, et al.
Publicado: (2021)

A comparison of the antianhedonic effects of repeated ketamine infusions in melancholic and non-melancholic depression
por: Zheng, Wei, et al.
Publicado: (2022)

The Montreal model: an integrative biomedical-psychedelic approach to ketamine for severe treatment-resistant depression
por: Garel, Nicolas, et al.
Publicado: (2023)

Impact of Repeated Doses of Subcutaneous Esketamine on Acute Dissociative Symptoms in Treatment-Resistant Depression
por: Del Sant, Lorena Catarina, et al.
Publicado: (2022)

Intravenous ketamine for depression: A clinical discussion reconsidering best practices in acute hypertension management
por: Yip, Ryan, et al.
Publicado: (2022)

Craving for Ketamine and Its Relationship With Clinical Outcome Indicators in Males With Ketamine Use Disorder
por: Wang, Peng-Wei, et al.
Publicado: (2021)

Controversies of the Effect of Ketamine on Cognition
por: Zhang, Melvyn W. B., et al.
Publicado: (2016)

Case Report: Repeated Series of Ketamine Infusions in Patients With Treatment-Resistant Depression: Presentation of Five Cases
por: Gałuszko-Wȩgielnik, Maria, et al.
Publicado: (2021)

A Retrospective Naturalistic Study Comparing the Efficacy of Ketamine and Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Depression
por: Mikellides, Georgios, et al.
Publicado: (2022)

Ketamine and Attentional Bias Toward Emotional Faces: Dynamic Causal Modeling of Magnetoencephalographic Connectivity in Treatment-Resistant Depression
por: Gilbert, Jessica R., et al.
Publicado: (2021)

Transcranial magnetic stimulation and intravenous ketamine combination therapy for treatment-resistant bipolar depression: A case report
por: Elkrief, Laurent, et al.
Publicado: (2022)

Safety, effectiveness and tolerability of sublingual ketamine in depression and anxiety: A retrospective study of off-label, at-home use
por: Hassan, Kazi, et al.
Publicado: (2022)

Subcutaneous ketamine in the treatment of depression and suicide risk: case report.
por: Cigognini, M. A., et al.
Publicado: (2023)

An Integrative Approach to Ketamine Therapy May Enhance Multiple Dimensions of Efficacy: Improving Therapeutic Outcomes With Treatment Resistant Depression
por: Muscat, Sherry-Anne, et al.
Publicado: (2021)

Cortical Thickness Changes in Chronic Ketamine Users
por: Zhong, Jun, et al.
Publicado: (2021)

Ketamine as a prophylactic resilience-enhancing agent
por: Evers, Audrey G., et al.
Publicado: (2022)

Level of Insight in Patients With Obsessive–Compulsive Disorder: An Exploratory Comparative Study Between Patients With “Good Insight” and “Poor Insight”
por: de Avila, Richard Chuquel Silveira, et al.
Publicado: (2019)

Computerized-Adaptive vs. Traditional Ratings of Depression and Suicidal Thoughts: An Assay Sensitivity Pilot Study in a Ketamine Clinical Trial
por: Grunebaum, Michael F., et al.
Publicado: (2021)

Case report: Effectiveness of brexpiprazole and esketamine/ketamine combination: A novel therapeutic strategy in five cases of treatment-resistant depression
por: Chan, Lai Fong, et al.
Publicado: (2022)

Case report: Intramuscular ketamine or intranasal esketamine as a treatment in four patients with major depressive disorder and comorbid anorexia nervosa
por: Keeler, Johanna Louise, et al.
Publicado: (2023)

Determination of HPV prevalence in oral/oropharyngeal mucosa samples in a rural district of São Paulo
por: Cavenaghi, Vitor Breseghello, et al.
Publicado: (2015)

Effects of Nicotine on the Neurophysiological and Behavioral Effects of Ketamine in Humans
por: Mathalon, Daniel H., et al.
Publicado: (2014)

The Antidepressant Effect of Ketamine Is Dampened by Concomitant Benzodiazepine Medication
por: Andrashko, Veronika, et al.
Publicado: (2020)

Ketamine-assisted psychotherapy in adolescents with multiple psychiatric diagnoses
por: Wolfson, Philip E., et al.
Publicado: (2023)

Suicide prevention and ketamine: insights from computational modeling
por: Charlton, Colleen E., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_euqsnbddjpaglv8sql7m85dj2g